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ABSTRACT
￿
We have recently discovered that cells of Coon's Buffalo rat liver (BRL) line secrete
a protein which is a potent inhibitor of skeletal myoblast differentiation in vitro. Using ion
exchange and molecular exclusion chromatography, we have prepared this protein, which we
designate "differentiation inhibitor" (DI), from the materials secreted by BRL cells maintained
in serum-free medium. It is a relatively heat-stable protein which is inactivated by treatment
with trypsin and mercaptoethanol and has an apparent molecular weight in the range
30,000-36,000. It exhibits no detectable mitogenic or lectin activity and differs from previously
reported inhibitors of myoblast differentiation in several respects. It is active in all skeletal
myoblast systems tested (Yaffe's L6 line as well as primary cultures of rat, chick, and Japanese
quail myoblasts), and it blocks fusion, elevation of creatine kinase, and increased binding of
a-bungarotoxin . Parallel fractionation of fetal bovine serum (FBS) and chick embryo extract
(CEE) yields a peak of activity which similarly inhibits myoblast differentiation. We suggest
that the differentiation inhibitorfrom BRL cells may correspond to the differentiation-inhibiting
component(s) of FBS and CEE, and we call attention to the possibility that such a substance
could play a role in embryonic growth of myoblasts and in satellite cell formation.
The mechanisms and control ofmuscle cell differentiation have
been matters ofactive interest since the feasibility ofmeasuring
this process in cultured cells was demonstrated two decades
ago. Two views have emerged: in essence, one states that the
process is reversibly controlled by components of the medium
without any requirement for DNA synthesis (1), and the other
proposes that an essential event occurs during a "quantal
mitosis" which gives at least one daughter cell irreversibly
committed to differentiate (2). Subsequent papers have re-
ported data interpreted as favoring one or the other view, but
in many cases the interpretation has been clouded by the
complex nature of uncharacterized medium components such
as embryo extract (3). It seems clear that manipulation of the
medium can substantially alter the time course of myoblast
differentiation, but the point in the cell cycle at which myo-
blasts become irreversibly committed to differentiation rather
than proliferation remains a matter of disagreement. This
situation might be clarified if the processes involved were
studied using defined medium components and cloned cells
rather than the complex mixtures used in most ofthe published
experiments.
A recent report from this laboratory (4) documents the
stimulation by the somatomedins of differentiation in cloned
L6 myoblasts grown in serum-free medium. Insulin at high
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concentrations (10-6 M) mimics this action of the somatome-
dins, probably by binding to the somatomedin receptor. During
that study, we noted an unexpected inhibition of myoblast
differentiation when cells were treated with crude preparations
of MSA (multiplication stimulating activity, a member of the
somatomedin family isolated from the medium of Buffalo rat
liver (BRL) cells grown in serum-free medium). This inhibition
did not occur with purified MSA and the inhibiting activity
could be partially separated from MSA by molecular exclusion
chromatography on Sephadex G-75. This paper is our initial
report of the discovery and biological activity of this agent,
which we have designated "differentiation inhibitor" (DI).
At present, the cell type specificity of DI action is a matter
of considerable interest to us. Accordingly, we invite inquiries
from investigators working with well-defined cell culture sys-
tems in which differentiation can be measured by morpholog-
ical and/or biochemical criteria as in myoblasts.
MATERIALS AND METHODS
Materials
Tissue culture supplies were purchased from Gibco Laboratories (Grand
Island Biological Co., Grand Island, NY). Insulin, bovine serum albumin (BSA,
RIAgrade), reagents for the creatine kinase assay, Dowex 50, and Sephadex G-
39575 were purchased from Sigma Chemical Co. (St. Louis, MO). All column
equipment was obtained from Pharmacia Fine Chemicals(Piscataway, NJ). BRL
cells were obtained from Dr. Gary L. Smith (University of Nebraska). Cells
cloned from Yaffe's L6 line (5) and selected for fusing (clone C1 and subclone
K44) or nonfusing (clone C5) properties were used throughout this study. "'I-
labeled a-bungarotoxin was a generous gift from Dr. Thomas Podleski (Cornell
University).
Preparation of the Differentiation Inhibitor
DI purification from BRLcell conditioned media follows the procedure used
in several laboratories for MSA purification (6). In a typical preparation, a 1.5 1
slurry of Dowex 50X8-100 (Nee` form) is added to 4I of BRL-cell-conditioned
medium; the mixture is stirred at room temperature at least 30 min. Theliquid
is then removed by filtration through a large (160-cm inner diameter) sintered
glass funnel. The resin is then washed three times with 2.5 1 of 0.9% (wt/vol)
NaCl and twice with 1.5 1 of 0.1 M NaHCOa (adjusted to pH 9.0 with NaOH).
The MSA-DI mixture is then eluted by two treatments with 700 ml of 0.1 M
NH,OH; the eluant is rapidly collected by vacuum filtration and immediately
adjusted to pH 5.5 by addition of 5 N HCI.
This eluate (designated Dowex MSA) is reduced to -200 ml by freeze-drying
and dialyzed against 20 vol of 2% acetic acid followed by 20 vol of I M acetic
acid. The dialyzed Dowex MSAis then lyophilized to dryness, taken up in 20 ml
of l Macetic acid, and fractionated on a 5.0 x 80 cm column ofSephadex G-75
(in 1 M acetic acid). As shown in Fig. 1, the peak of DI follows the excluded
volume and just precedes the broad peak which contains several subspecies of
MSAactivity. (In initial preparations, DI activity was localized in the excluded
peak; this ledto an erroneousinitialindication that itsmolecular weight exceeded
80,000. However, we have found that it is tightly bound to the Cybacron Blue
F3G-A chromophore in Blue Dextran; the results in Fig. 1 were obtained on a
column run in the absence of Blue Dextran.) The DI-containing fractions were
combined, frozen, and used for the experiments reported here. Thepurification
procedure and its results are summarized in Table 1.
40 GO
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FIGURE 1 Fractionation of DI and MSA on Sephadex G-75. BRL-
cell-conditioned medium was fractionated by batchwise absorption-
elution on Dowex 50 as described under Methods. A 20-ml aliquot
(containing 20-30 mg of Dowex MSA) was applied to a 5.0 x 80-cm
column of Sephadex G-75-120 and fractionated in 1 M acetic acid
at room temperature. Fractions (19 ml) were analyzed for protein,
MSA, and DI activity as described under Materials and Methods.
The elution peaks of molecular weight markers (ov, ovalbumin;
myo, myoglobin; ins, insulin) used in calibrating the column are
indicated at the top of the figure.
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Cell Culture
Unless otherwise specified, L6 myoblast cultures were prepared by plating 5
x 10' cells/4 cm' well (in Costar 12-well plates) in 2 ml Dulbecco's modified
Eagle's medium (DME) containing 2.5% horse serum and 0.5% chick embryo
extract. After incubation for 24 h at 37°C in 95% air-5% C02. the cells were
washed for 15 min with DME before the components studied were added in
DME containing 0.5 mg/ml BSA. Quail and chick primary skeletal myoblasts
were prepared as described by Konigsberg (7). Primary rat skeletal myoblasts
were prepared by the method ofYaffe (8).
Assays of Myoblast Differentiation
Creatine kinase (CK) activity was the primary indicator of myoblast differ-
entiation used in measuring activity of the DI. After the specified incubation
periods, myoblast cultures were rinsed twice with phosphate-buffered saline (pH
7.2), covered with 100 WI of glycylglycine buffer (0.05 M, pH 6.8) and stored at
-60°C. On the day the assays were done, cells were thawed, scraped from the
dish with a rubber policeman, and vortexed. Aliquots (33 1xl) were assayed for
CK activity by the method of Shinberg et al. (9), and 50 pl of the remaining
suspension was taken for analysis of DNA(10) and protein content (11).
In some experiments, fusion was also evaluated by determining the percent
nuclei in myotubes; forthis, the cultures studied were fixed at the specified times
with methanol and stained with Wrights-Giemsa stain (12). Nuclei in random
fields were counted until a total of800-1,000 nuclei was reached.
a-Bungarotoxin binding was measured after washing the cell surfaces with
Earle's balanced salt solution (BSS) containing BSA (2 mg/ml). For determina-
tion of nonspecific binding, 10' M unlabeled bungarotoxin was added to half
the cultures and incubated at room temperature for 20 min. Solutions containing
the unlabeled toxin were removed and all cultures then incubated with "5I-a-
bungarotoxin in 0.6 ml Earle's BSScontaining BSA for 30 minat room temper-
ature. Cell surfaces were washed three times with Earle's BSS containing BSA
for 5 min each. Thecells were solubilized with 0.8 ml of0.5 NNaOH for 3 h and
binding determined by counting in a Beckman Model 4000 gamma counter
(Beckman Instruments, Inc., Electronic Instruments Div., Schiller Park, IL).
Specific binding was calculated in the customary manner by subtracting nonspe-
cific from total binding for each experimental condition.
RESULTS
Effect of DI on Myoblast Differentiation
The concentration dependence of DI action on L6 myoblast
differentiation is illustrated in Fig. 2. These effects of DI are
not restricted to the L6 myoblast line; as shown in Table II, we
have found similar inhibition in primary myoblasts cultured
from rat and Japanese quail muscle (whether expressed on a
per culture or per cell basis), as well as in chick myoblasts.
All tested aspects of myoblast differentiation were inhibited
by DI; Fig. 2 documents the effects on fusion and creatine
kinase elevation in L6 myoblasts, The effects of the inhibitor
on a-bungarotoxin binding were also measured in experiments
in which we assessed the potential usefulness of this system for
routine assays during DI purification. The results of one such
experiment are summarized in Table III; although they show
a cleareffect in inhibiting formation of acetylcholine receptors,
the procedure had no advantages in sensitivity, convenience,
speed, or economy over the determination of creatine kinase
levels, so we chose the latter as our standard for DI determi-
nations.
-0.2 0 0.2 0.4 0.6
Lg PROTEIN CONC. (ug/ml)
FIGURE 2 Effects of DI on
myoblast fusion and elevation
of CK. L6-K44 myoblasts were
plated as described under Ma-
terials and Methods. 60 h after
the addition of 10-6 M insulin
and DI (at the specified con-
centrations) plates were proc-
essed and creatine kinase or
fusion measured as specified
under Materials and Methods.
Partial Purification of the
TABLE I
DI from BRL Conditioned Medium 100
Total Purifi- ó a
80
Purification activ- Total pro- Specific cation % Re-
step ity tein activity factor covery
° 60
U ,ug U/rng û 40
BRL conditioned 858 260,000 3.3 - 100
medium 20F
Dowex 50 660 20,000 33 10 76.9
Sephadex G-75 486 694 700 216 56.6 0nd, no data.
* Primary rat and quail skeletal myoblast cultures were prepared as described under Materials and Methods. Cells were plated at 1 x 10^ cells/cm' in 8 cm2 plates
in DMEM containing 10% CEE and 15% horse serum. After 24 hours, the plates were rinsed with DMEM and fresh medium (containing 1% horse serum (for rat
cells) or 0.2% horse serum (for quail cells) plus the specified additions in DMEM with 0.5 mg/ml BSA). Sephadex-purified Differentiation Inhibitor wasadded
at a final concentration of 10 Kg/ml. Samples were analyzed 60 hours after the medium change, and the data are means ± SEM of triplicate determinations .
TABLE III
Effect of Differentiation Inhibitor on Bungarotoxin Binding to
Quail Muscle Cell Culture
"'I_a-Bungarotoxin bound (cpm/mg protein)
* Quail myoblasts were prepared as described by Konigsberg (7) and plated
at 5 x 10^ cells/4 cm2 well in DMEcontaining 15% horse serum, 10% CEE,
and 3.6 ug/ml DI in Costar 12-well plates. After 19 h, the cultures were
washed with serum-free DMEand then fresh medium comprised of 10-6 M
insulin, 1% horse serum in DME:Ham's F-12 (1 :1) (with and without DI as
indicated) wasadded. After48 h, binding of '251-a-bungarotoxin wasmeas-
ured as described under Materials and Methods. Data are means ± SEMof
triplicate determinations .
Action of the DI was sustained for an extended period when
fresh inhibitor was added at 24-h intervals (Fig. 3). Reversibil-
ity of DI action was indicated by the observation that 62% of
nuclei were found in myotubes 48 h after the inhibitor was
removed by gently washing the cell surfaces and adding fresh
(inhibitor-free) medium at the end ofthe experimentillustrated
in Fig. 3. Further evidence that the DI had no injurious effects
on the cells is shown in Fig. 4; the morphology of myoblasts
treated up to 72 h with DI was not detectably different from
that of cells at the beginning of the treatment. The relatively
long time before fusion was observed after DI removal suggests
that it blocks an early event in the differentiation ofmyoblasts.
This view is supported by the results of the experiment sum-
marized in Fig. 5; the DI had little effect when added 24 h
after insulin was added to stimulate myoblast differentiation,
although there was no detectable fusion of L6 cells at the time
the inhibitor was added.
Determination of the Mitogenic Activity
of the Of
It has been reported that some (13) but not all (4) mitogens
inhibit the differentiation of myoblasts. Thus it was of partic-
ular interest to determine the mitogenic activity of the DI, As
shown in Table IV, the partially purified (i.e., MSA-free) DI
used in these experiments had no detectable mitogenic activity
either in the rapidly fusing K44 clone or the nonfusing C5
N
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0
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FIGURE 3 Persistence of the
action of DI on myoblasts. L6-
C1 myoblast cultures were
prepared as described under
Materials and Methods. At
zero time, insulin (10-6 M) in
the presence or absence of DI
(10 ILg/ml of Sephadex-puri-
fied material) was added to
the cultures. Daily medium
changes (arrows) were made
with the addition of fresh in-
sulin and DI . Points indicate
means and bars represent SEM
of triplicate determinations.
clone of L6 myoblasts. It should be noted that the Inhibitor
preparation was added at 3.6 tLg/ml, a concentration which
gave >90% inhibition of myoblast differentiation in a parallel
experiment (see Fig. 2). The DI exhibited no mitogenic activity
when it was added alone or in the presence of mitogens (and
fusion-stimulating agents) such as insulin and MSA. The latter
are the conditions in which we routinely assay DI activity;
indeed, in this experiment inhibition of fusion in the K44 cells
incubated with DI and either MSA or insulin was observed
microscopically at 48 h. In fact, the loss of countable myoblasts
as they fused to form myotubes gave results which could be
misinterpreted to indicate a mitogenic action of the DI if only
the 48 h data for MSA and insulin in the K44 clone were
considered. In these cases, the number of myoblasts counted
decreased substantially as the cells fused between 24 and 48 h,
thus giving higher cell counts in the cultures in which fusion
was prevented by the DI. There was no such decrease in the
nonfusing C5 clone under parallel conditions.
It should be noted (Table IV) that DI neither enhanced nor
inhibited the growth-promoting actions of MSA or insulin;
these observations are consistent with results of experiments
which indicated that the inhibitor has no effect on the binding
of Ts.I-MSA to myoblasts (M. R. Benedict and J . R. Florini,
unpublished observations) or the degradation of "'I-insulin
(D. Z. Ewton, unpublished observations).
In routine determinations of DNA (part of our standard DI
assays), control and DI-treated cultures consistently exhibited
DNA levels within 10-15% ofeach other; this was also the case
in experiments with Japanese quail myoblasts (Table II). It
should also be recalled that the DI can be detected in Sephadex
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Addition Total Nonspecific Specific
Con-
trol
F o.a
None (con- 3,670 ± 90 1,250 ± 22 2,420 ± 93 100 á
trol) á
DI 2,460 ± 148 1,460 ± 75 1,000 ± 166 41 0
Conditions
Effects of DI on Rat
TABLE II
and Quail Primary Myoblasts
CK Level
Myoblast source
Addition to
medium No DI +DI No DI +DI
U CK/culture U CK/mg DNA
Rat
None 193 ± 3.6 92 ±8.3 nd nd
10-6 M Insulin 267 ± 8.3 121 ±4.2 nd nd
Quail
None 77.1±2.1 27.1±4.8 28.9±1 .7 9.7±1.0
10-6 M Insulin 145.8±18.1 43.8±6.3 36.4±5.3 11 .2±2.0FIGURE 4
￿
Morphology of L6 myoblasts before and after treatment with the DI . Cells were plated in 8-cm' plates as described
under Materials and Methods . Insulin (10-s M) in the presence and absence of DI was added at zero time (24 h after initial
plating) . At the specified times, plates were washed with phosphate-buffered saline, fixed in methanol, and then stained with
Wright-Giemsa . For the Controland Effect of DI columns, these times (in hours) are measured from the initial addition of insulin .
For the Recovery from DI column, the times are the interval after removal of DI and addition of fresh insulin to cultures which had
been exposed to insulin and DI for 72 h ; thus, these cultures were treated with insulin and DI for 72 h and then allowed to recover
for an additional 24-72 h as indicated . x 80.
G-75 column fractions which are inactive in the 3H-thymidine
incorporation assay for MSA activity (Fig . 1) . We conclude
from this extensive set of observations that the DI is not a
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mitogen, at least for myoblasts and chick embryo fibroblasts
under conditions and at concentrations at which it exhibits full
activity in inhibiting fusion and elevation ofCK in myoblasts .Partial Characterization of the DI
Although free of detectable mitogenic activity, the DI is not
yet pure. SDS gel electrophoresis and silver staining reveal the
presence of at least five bands, but available quantities are not
yet sufficient for rigorous evaluation of the purity and subunit
structure of the DI. Nevertheless, some properties of the mol-
ecule can be established even with the impure preparations
currently available. On the basis of its elution from Sephadex
G-75, the DI has a molecular weight of 30,000-36,000; for this
estimate, the column was calibrated using ovalbumin, myoglo-
bin, and insulin as molecular weight standards (as shown in
Fig. 1). DI activity is destroyed by treatment with trypsin or
mercaptoethanol. It is relatively stable to heating; activity is
not lost upon heating at temperatures up to 70°C for 10 min,
although it is destroyed at 80°C and higher temperatures. It is
quite stable in 1 M acetic acid at room temperature; these are
the conditions in which the Sephadex G-75 column is run. Our
most highly purified preparations exhibited no hemagglutina-
tion activity for erythrocytes at concentrations as high as 25
tLg/ml underconditions (14) in which concanavalin A exhibited
full activity. Purification and characterization of the DI mole-
cule will be the subject of a subsequent publication.
Presence of a Similar Inhibitor in Fetal Bovine
Serum and Chick Embryo Extract
High concentrations of fetal bovine serum (FBS) and/or
chick embryo extract (GEE) are frequently used to suppress
fusion during the growth of myoblast stock cultures. In initial
experiments (S. C. Seifert and J. R. Florini, unpublished
observations), we have found that fractionation of FBS and
CEE by the procedure used for DI production yields a peak
(in molecular exclusion chromatography on Sephadex G-75)
of inhibitor activity very similar to that of the DI from BRL
cells (Fig. 1). This material precedes (and slightly overlaps) a
peak of mitogenic activity which presumably corresponds to
the serum MSA described by Pierson and Temin (15) a decade
ago. The relationship of the differentiation inhibiting compo-
nents of FBS and CEE to the BRL cell DI is currently under
investigation.
Clone
Additions to me-
DISCUSSION
FIGURE 5
￿
Effect of time of
addition of DI on myoblast
differentiation. L6-C1 my-
oblasts were plated as de-
scribed under Materials
and Methods. At zero time,
the medium was changed
to DME insulin (10-6 M) ;
DI was added at the plot-
ted times by adding 0.2 ml
of a 100 yg/ml solution to
2 ml medium in each plate.
All cultures were processed
for CK assay 60 h after the
addition of insulin. Data
are presented as in Fig. 2.
TABLE IV
Determination of Mitogenic Activity of the Differentiation Inhibitor
After our discovery of a differentiation-inhibiting material in
BRL cell-conditioned medium, our initial experiments were
devoted to evaluation of some possible trivial explanations for
DI action and to comparisons with other agents reported to
affect myoblast differentiation. From these, we reached the
following series of conclusions.
The DI does not act by degrading insulin or MSA (which
we use to stimulate differentiation in the serum-free medium
in which these experiments are done); it blocks fusion in dense
cultures incubated in the absence of these hormones. Further-
more, it does not affect the mitogenic (Table IV) or other (16,
17) actions of these hormones in myoblasts, does not degrade
the iodinated hormones, and does not inhibit the binding of
1251-MSA to myoblasts.
There are several reasons for concluding that it is not iden-
tical to the somatomedin-binding protein (which is also se-
creted by BRL cells (18)): (a) the action of DI is not overcome
by large quantities of MSA or insulin (more than sufficient to
saturate the binding protein); (b) it does not affect any actions
ofthese hormones other than the stimulation ofdifferentiation;
(c) the binding protein does not bind insulin significantly (19)
and thus would not affect the stimulation of differentiation by
insulin, and (4) its apparent molecular weight is lower than
that of the binding protein.
10-° x cells/cm2
á 100
z 0 ü
f-
w
á
á
0
* Cells were plated at -1.2 x105 cells/4 cm2 well in DMEM containing 2% horse serum and 0.4% CEE in Costar 12-well multiwell plates. Cultures were incubated
at 37°C for 5 h to allow attachment of the cells, and then washed briefly with serum-free DMEM. At this time (designated zero time), sample K44 cultures
contained 2.50 ±0.05 x 10` cells/cm', and parallel C5 cultures contained 3,69 t 0.06 x 10° cells/cm2. The indicated compounds were then added in DMEM
to give the following final concentrations : 10-5 M insulin, 1 .0Ag/ml MSA, 5% (vol/vol) horse serum, and 3.6 Ag/ml of partially purified DI (fre of MSA). At the
specified time, cells were lifted by trypsinization and counted using a Model ZBI Counter Counter. Data are means ±SEM of triplicate cultures.
$ Extensive myotube formation was observed in these cultures, and in no others in this experiment.
§ Significantly (P<0.05) larger than the corresponding 48-h culture incubated in the absence of the DI.
EviNGER-HOOGES ET AL .
￿
ADifferentiation Inhibitor from LiverCells
￿
399
dium No DI + DI
24 h
No DI +Dl
48 h
K44
None (control) 2.64 ± 0.06 2.74 ±0.09 2.57 ± 0.20 2 .33 t 0.02
Insulin 4.60 t 0,37 4.83 t0.35 3.28 ± 0.06$ 5.23 ± 0.12§
MSA 3.38 ± 0,16 3.29 ±0.15 2.32 t 0.06$ 5.09 ± 0.07§
Horse serum 4.49 ± 0.04 3.86 ±0.08 8.65t0.11 6.05±0.05
C5
None 6.09 ± 0.26 6.18 ±0.25 5.11 ±0.07 5.16±0.10
Insulin 8.88 ± 0.53 8.56 ±0.65 10.42±0.54 10.18±0.51
MSA 7.28 ± 0.09 7.40 ±0.11 8.34 ± 0.37 9.45 ± 0.25
Horse serum 8.71 ± 0.22 8.37 ± 0.56 18.45±0.37 16.38±0.08Finally, the DI does not appear to act by reducing available
Ca" below the level required for myoblast fusion; increasing
the medium CaC12 by an additional 1.4 mM did not reverse
the action of the DI. Furthermore, inhibition of fusion by
partially purified DI (at 3.6 Ittg/ml) would require that each
molecule of the protein (assuming a molecular weight of
30,000) bind nearly 10,000 Ca" ions to reduce calcium from
the 1.8 mM level in Dulbecco's medium to the 0.3 mM level
which does not allow fusion in these cells.
With the exception of the inhibitor of fusion in CEE de-
scribed by Slater (3), the DI does not appear to correspond to
inhibitors of fusion previously described in the literature. Its
lack of hemagglutinating activity, as well as its heat and acid
stability, contrasts sharply with the lectins studied by several
othergroups (20-24). Thelectin with properties closest to those
we have observed is probably Podleski's "myonectin", but the
DI is quitestable to exhaustive dialysis, is relatively heat-stable,
andis notinactivated as aresult of theloss ofasmall stabilizing
molecule duringgelfiltration; allofthese differfrom myonectin
(24;T. R.Podleski, personal communication). There areseveral
differences in actions and/or stability between our DI and the
fusion-inhibiting lectin described by MacBride and Przybylski
(23); for example, the action of DI persists for at least 96 h
when it is replaced daily, while chick cells overcome the effect
of the lectin after afew days of dailyrenewal. The secretion of
DI into thesoluble portion ofBRL cell medium is an additional
indication that it is not a typical lectin; these compounds are
usually associated with cell membranes or are bound to the
culture dish surfaces. There are several additional reasons to
conclude that the DI is not fibronectin or a closely related
protein. Its solubility at neutral pH, lack of lectin activity,
action on primary myoblasts as well as L6 cells, and ready
reversibility are different from reported properties or actions
of fibronectin in inhibiting muscle cell differentiation.
The complete lack of mitogenic activity of the DI contrasts
sharply with fibroblast growth factor (FGF), which has been
shownby Linkhart et al. (13) to inhibit differentiationin mouse
myoblasts. The DifferentiationInhibitorexhibits some similar-
ities to the acid-activated inhibitor to 3T3-adipocyte differen-
tiation recently found in FBS by Kuri-Harcuch and Green
(25), but BRL-cell-conditioned medium is fully active even
without any acid treatment, and the activity of non-acidified
FBS in blocking myoblast differentiation has been observed in
many laboratories.
The physiological significance of the DI remains to be
investigated. However, there are reasons to believe that it may
play an important biological role. The BRL cell line was
derived from liver cells ofyoung rats (26) and it is best known
for its secretion of a protein, MSA, which is found principally
in the fetal circulation (6). This is consistent with our prelimi-
nary observation that the DI corresponds to the component of
FBS and CEE which suppresses fusion of myoblasts in
"enriched" media (1, 5). It is possible that inactivation of the
DI, rather than degradation of mitogens, accounts for the
accelerated fusion of myoblasts in "exhausted" medium ob-
served by many investigators working with muscle cells.
We are particularly interested in the possibility that the DI
could regulate fetal growth and development of muscle. If, as
the behavior of muscle cells in culture suggests, myoblasts are
capable of differentiation whenever sufficient cell density and
appropriate cell environment coincide, then it is possible that
the DI suppresses precocious fusion of myoblasts to form
postmitotic myotubes untillate in development, when adequate
400
￿
THE JOURNAL Or CELL BIOLOGY - VOLUME 93, 1982
accumulation of myoblasts has occurred. (This view assumes
that the levels or actions of DI decrease late in development.)
In addition, localized high concentrations of DI could be
responsible for the inclusion of undifferentiated myoblasts as
satellite cells on the periphery of mature muscle fibers (27).
Thus our discovery of the DI opens a number of possibilities
forfurther investigation.
In summary, the results presented here demonstrate that
BRL cells secrete a protein which exhibits potent activity in
inhibiting the differentiation of myoblasts in culture. Action of
the DI is not accompanied by any detectable effect on prolif-
eration or viability of myoblasts, and differentiation proceeds
normally upon removal of the inhibitor. The DI is active in
inhibiting all measured aspects of myoblast differentiation
(fusion, CK elevation, and a-bungarotoxin binding) in all
myoblastsstudiedthus far; this includes muscle cells from rats,
chickens, and Japanese quail, as well as Yaffe's L6 line of rat
myoblasts. Thus it appears that the DI secreted by BRL cells
may be an important tool for the study of muscle differentia-
tion.
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